Items where Author is "Chau, David Y.S."

Number of items: 25.
Article
  • In Vitro Cell Models for Ophthalmic Drug Development Applications. (2016) Sara Shafaie, Victoria Hutter, Michael T. Cook, Marc Brown and David Y.S. Chau
  • An Overview of Tissue Engineering as an Alternative for Toxicity Assessment. (2016) Mathew Garrod and David Y.S. Chau
  • Cross-linking of collagen I by tissue transglutaminase provides a promising biomaterial for promoting bone healing. (2014) Dario Fortunati, David Y.S. Chau, Zhuo Wang, Russell John Collighan and Martin Griffin
  • Digoxin net secretory transport in bronchial epithelial cell layers is not exclusively mediated by P-glycoprotein/MDR1. (2014) Victoria Hutter, David Y.S. Chau, Constanze Hilgendorf, Alan Brown, Anne Cooper, Vanessa Zann, David I. Pritchard and Cynthia Bosquillon
  • The development of a 3D immunocompetent model of human skin. (2013) David Y.S. Chau, Claire Johnson, Sheila MacNeil, John W. Haycock and Amir M. Ghaemmaghami
  • Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. (2012) Ellen Bible, Omar Qutachi, David Y.S. Chau, Morgan R. Alexander, Kevin M. Shakesheff and Michel Modo
  • Severe conjunctivochalasis in association with classic type Ehlers-Danlos syndrome. (2012) John K. Whitaker, Philip Alexander, David Y.S. Chau and Naing L. Tint
  • Tissue transglutaminase (TG-2) modified amniotic membrane : a novel scaffold for biomedical applications. (2012) David Y.S. Chau, Sheridan V. Brown, Melissa L. Mather, Victoria Hutter, Naing L. Tint, Harminder S. Dua, Felicity R. A. J. Rose and Amir M. Ghaemmaghami
  • Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype - implications for the role of transglutaminase in coeliac disease. (2012) William J. Dalleywater, David Y.S. Chau and Amir M. Ghaemmaghami
  • Combination of Injectable Multiple Growth Factor-Releasing Scaffolds and Cell Therapy as an Advanced Modality to Enhance Tissue Neovascularization. (2010) Jaimy Saif, Theresa M. Schwarz, David Y.S. Chau, James Henstock, Paramjit Sami, Simon F. Leicht, Patrick C. Hermann, Sonia Alcala, Francisca Mulero, Kevin M. Shakesheff, Christopher Heeschen and Alexandra Aicher
  • The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticles. (2010) David Y.S. Chau, Naing L. Tint, Russell J. Collighan, Martin Griffin, Harminder S. Dua, Kevin M. Shakesheff and Felicity R. A. J. Rose
  • Laminin and Fibronectin Treatment Leads to Generation of Dendritic Cells with Superior Endocytic Capacity. (2010) Samuel Garcia-Nieto, Ramneek K. Johal, Kevin M. Shakesheff, Mohamed Emara, Pierre-Joseph Royer, David Y.S. Chau, Farouk Shakib and Amir M. Ghaemmaghami
  • The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. (2009) Ellen Bible, David Y.S. Chau, Morgan R. Alexander, Jack Price, Kevin M. Shakesheff and Michel Modo
  • The effect of delivery via narrow-bore needles on mesenchymal cells. (2009) Kapil Agashi, David Y.S. Chau and Kevin M. Shakesheff
  • Attachment of stem cells to scaffold particles for intra-cerebral transplantation. (2009) Ellen Bible, David Y.S. Chau, Morgan R. Alexander, Jack Price, Kevin M. Shakesheff and Michel Modo
  • Life support systems for cell therapies. (2009) K. Agashi, David Y.S. Chau and Kevin M. Shakesheff
  • In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. (2008) Qingpu Hou, David Y.S. Chau, Chayanin Pratoomsoot, Patrick J. Tighe, Harminder S. Dua, Kevin M. Shakesheff and Felicity R. A. J. Rose
  • A novel self-sintering microparticle-based system for regenerative medicine. (2008) S.Y. Lee, K. Agashi, David Y.S. Chau and Kevin M. Shakesheff
  • Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. (2006) R. A. Jones, P. Kotsakis, T. S. Johnson, David Y.S. Chau, S. Ali, G. Melino and M. Griffin
  • The cellular response to transglutaminase-cross-linked collagen. (2005) David Y.S. Chau, R.J. Collighan, E.A.M. Verderio, V.L. Addy and M. Griffin
  • Other
  • Improving treatment of stroke through nanotechnology. (2013) F Nicholls, N Gorenkova, Ellen Bible, C Franco, David Y.S. Chau, Christos Tolias, Kevin Shakesheff, JL West and Michel Modo
  • Transplantation of Human NSCs on VEGF-Releasing Microparticle Scaffolds in a Stroke Model. (2010) Ellen Bible, David Y.S. Chau, M. R. Alexander, J. Price, Kevin M. Shakesheff and Michel Modo
  • Microparticles as tissue engineering scaffolds : manufacture, modification and manipulation. (2008) David Y.S. Chau, K. Agashi and K. M. Shakesheff
  • A biosynthetic bandage for corneal wound repair. (2008) Chayanin Pratoomsoot, Qingpu Hou, David Y.S. Chau, H. Tanioka, K. Hori, S. Kawasaki, S. Kinoshita, Patrick J. Tighe, Harminder Dua, Kevin M. Shakesheff and Felicity R. A. J. Rose
  • Collagen: Structure and modification for biomedical applications. (2007) David Y.S. Chau, Russell J. Collighan and Martin Griffin